Skip to main content
OpenTrials

Clinical trial condition

Immune-mediated Focal Segmental Glomerulosclerosis (FSGS)

Explore clinical trials studying Immune-mediated Focal Segmental Glomerulosclerosis (FSGS). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Immune-mediated Focal Segmental Glomerulosclerosis (FSGS) trial results

Active, Not Recruiting

A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of VIS171 in Participants With Autoimmune Disease(s)

NCT06799520

Conditions
Alopecia, Alopecia Areata, Alopecia Areata (AA), +10 more
Locations
  • Visterra Investigational Site Sofia, Bulgaria
  • Visterra Investigational Site Chisinau, Moldova
  • Visterra Investigational Site Bucharest, Romania
  • Visterra Investigational Site Cluj-Napoca, Romania
View Trial Details

Related conditions